APUS
Apimeds Pharmaceuticals US, Inc. Common Stock (APUS)
$22
About Apimeds Pharmaceuticals US, Inc. Common Stock (APUS)
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.
Details
Daily high
$4.16
Daily low
$3.10
Price at open
$4.10
52 Week High
$59.70
52 Week Low
$1.51
Market cap
6.2M
Dividend yield
-
Volume
138,716
Avg. volume
6.8M
P/E ratio
-.11
Apimeds Pharmaceuticals US, Inc. Common Stock News
Details
Daily high
$4.16
Daily low
$3.10
Price at open
$4.10
52 Week High
$59.70
52 Week Low
$1.51
Market cap
6.2M
Dividend yield
-
Volume
138,716
Avg. volume
6.8M
P/E ratio
-.11